Drugmaker Halves Price of Potentially Promising Coronavirus Treatment
Sydney Otomancek2023-11-15T16:54:31-05:00March 23rd, 2020|Categories: Featured, Industry News|Tags: chloroquine, Coronavirus, Healtheconomics.com, HEOR, Rising Pharmaceuticals|
New Jersey-based Rising Pharmaceuticals doubled the price of chloroquine in 2019, but the drugmaker, in response to the coronavirus pandemic, [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Tuesday, December 5, 2023
Sponsor: ICON
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Friday, November 10, 2023
Sponsor: OpenHealth
Cell & Gene Therapies – Beginning with the End in Mind
Thursday, November 2, 2023
Sponsor: Magnolia Market Access
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication